Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche facility

This article was originally published in The Tan Sheet

Executive Summary

New biotech center in Grenzach, Germany "will develop biotechnological production processes" for vitamins, carotenoids, new products and "perform scale-up of processes from laboratory to full technical scale," Vitamins & Fine Chemicals division says Nov. 15. Facility "will also provide the necessary data for the construction of production plants as well as for the successful implementation of the processes," Roche notes. Biotech center joins facility in Kaiseraugst, Switzerland; proximity of operations is cited as "key advantage" for company to remain cost leader. Roche announced plans to divest Vitamins & Fine Chemicals unit to DSM in September (1"The Tan Sheet" Sept. 9, 2002, p. 6)...

You may also be interested in...



DSM To Acquire Leading Position In Vitamin Supply Market With Roche Deal

Dutch life sciences and performance materials producer DSM will enter the vitamin and carotenoid supply business at the top with the planned acquisition of Roche's Vitamins and Fine Chemicals division

Grail Starts PATHFINDER Trial To Evaluate Multi-Cancer Blood Test For Early Cancer Detection

Grail announced it will enroll about 6,200 people in an interventional, multi-center study evaluating its multi-cancer early-detection blood test. This is the first time health care providers will use this test to help guide patient care.

Future Use Of Titanium Dioxide In Spray And Powder Cosmetics Hinges On SCCS Review

As of 5 February, the Scientific Committee on Consumer Safety is evaluating use of titanium dioxide – now officially classified as a Category 2 carcinogen in the EU – in cosmetic products that can expose consumers by way of inhalation. Without a favorable SCCS opinion, the ingredient’s use in those contexts will be banned under Article 15 of the Cosmetics Regulation.

Topics

UsernamePublicRestriction

Register

PS094828

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel